Data provides the means for analysts to predict all manner of life events, including using health data to predict patient deterioration. However, aggregating and analysing data is such a time-consuming process that it is almost impossible to get a holistic view of a patient's health and predict the best courses of action.
Biofourmis provides an ML-driven healthcare predictive analytics platform, aggregating patient data and using ML to analyse the data, streamline connections between patients and care teams, and ultimately predict health outcomes. The platform integrates directly with existing software for care providers, pharmacies, patients, and healthcare payers, helping to reduce healthcare costs by increasing data transparency, optimising care plans, and reducing re-admission rates.
Whilst the company faces competition from other ML-driven healthcare data analysis platforms, Biofourmis stands out by providing its services to all parties, not just healthcare providers - an approach which provides the benefits of AI-assisted healthcare whilst reducing existing communication friction. Having surpassed unicorn status in 2022, the company has been focused on expanding operations, including by scaling its virtual care offerings and securing further high-value partnerships.
Kirsty
Company Specialist at Welcome to the Jungle